Mylan is challenging the patent protection on a drug used to treat fibromyalgia, prompting a lawsuit from the branded drug's manufacturers.
A drug under development by Forest Labs and Pierre Fabre "significantly" reduced symptoms of major depressive disorder, the companies said Wednesday.
Patients taking an investigative antidepressant undergoing late-stage clinical development showed “significant” improvement, according to study results released Monday.
A drug for major depressive disorder worked better than placebo, according to results of a late-stage clinical trial announced Thursday.
A hypothetical fibromyalgia drug that improved sleeping quality better than the top-selling drugs on the...